+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Devices Market - Global Forecast 2026-2032- Product Image
Drug Delivery Devices Market - Global Forecast 2026-2032- Product Image
New

Drug Delivery Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337868
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug delivery devices market is experiencing a period of accelerated change, fueled by evolving patient expectations, increasingly sophisticated technologies, and the need for compliance with diverse regulatory frameworks. Strategic foresight is essential for senior leaders aiming to maintain competitive advantage and operational resilience in this dynamic sector.

Market Snapshot: Drug Delivery Devices Market Overview

The drug delivery devices market expanded from USD 278.55 billion in 2025 to USD 310.07 billion in 2026 and is projected to continue its trajectory, achieving a compound annual growth rate (CAGR) of 11.56% to reach USD 599.37 billion by 2032. Key factors driving growth include rising therapeutic complexity, widespread adoption of patient-centric solutions, and heightened regulatory scrutiny. Across all geographies, device manufacturers are responding to demand for tailored, compliance-ready solutions aligned with patient safety and market access requirements.

Scope & Segmentation of the Global Drug Delivery Devices Market

  • Container Types: The market encompasses pre-filled syringes, auto-injectors, pen injectors, inhalers, insulin pumps, nebulizers, transdermal patches, and jet injectors, each engineered for specific therapeutic needs and routes of administration.
  • Material Types: Devices are produced using traditional glass as well as advanced polymers, both tailored for optimal safety, molecular stability, and user comfort in various clinical settings.
  • Device Mechanisms: Mechanisms include manual activation, spring-loaded systems, gas propulsion, and electronically integrated platforms, providing a range from simple to technologically sophisticated administration options.
  • Applications: Drug delivery devices are used for biologics, small molecules, and specialty formulations targeting acute and chronic medical conditions, with adaptations to support emerging therapies.
  • Patient Segments: Key focus areas include diabetes care, growth hormone management, respiratory disorders, and allergic response treatment, reflecting the broad therapeutic reach and customization of device offerings.
  • Geographies: Analysis spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, accounting for varying regulatory environments, patient populations, and commercial requirements.
  • Technology Features: Many devices now embed digital functionality for remote monitoring and user adherence support, further integrating connected health capabilities into daily practice and care management.

Key Takeaways: Strategic Priorities in Drug Delivery Devices

  • Adoption of patient-centric design is critical, as devices are increasingly evaluated on the basis of user adherence and their impact on clinical outcomes.
  • Advanced polymers and emerging microfabrication methods are being introduced to address durability and flexibility, reducing risks of device failure and improving patient comfort.
  • Integration of digital health capabilities, such as real-time adherence measurement and remote management, is supporting higher standards of chronic disease care and operational efficiency.
  • Payers and healthcare systems are prioritizing data-driven evidence for device adherence and efficacy, influencing both design choices and long-term commercial strategies.
  • Trade-offs in device configuration—spanning materials, capacities, and mechanisms—carry regulatory and usability implications, requiring customized development and commercialization pathways.
  • Manufacturers must present both clinical and economic justification to satisfy distinct regional regulatory frameworks and reimbursement models, necessitating flexible market strategies and localized value propositions.

Tariff Impact: Procurement and Supply Chain Adaptation

Recent tariff policies in the United States have created new pressures on sourcing imported device components. Procurement teams are diversifying supplier networks, engaging with partners in lower-tariff jurisdictions, and investing in domestic or closer-to-home manufacturing. These shifts increase procurement cycle duration and drive greater inventory transparency, while encouraging companies to build buffer stocks for supply chain stability. There is a reinforced emphasis on seamless trade compliance and regulatory partnerships to mitigate operational risk.

Methodology & Data Sources

This report’s findings are grounded in triangulated primary interviews with senior professionals in R&D, regulatory affairs, and commercial leadership, as well as a thorough secondary review of regulatory documents, published studies, and official market disclosures. Synthesis included multi-functional review panels and rigorous validation across device segments for consistent, actionable outputs.

Why This Report Matters

  • Equips executive teams to make data-driven decisions for product design, supply chain management, and partner evaluation in the drug delivery devices market.
  • Delivers a detailed assessment of segment-specific trade-offs—spanning materials, mechanisms, and clinical applications—to support strategic development and regulatory planning.
  • Provides targeted insights into regional market dynamics, enabling senior leaders to optimize global commercialization strategies and enhance success rates.

Conclusion

To achieve sustained growth and leadership, senior decision-makers should adopt a platform-based approach, prioritize adaptive supply chains, and generate robust real-world evidence. Integration of design, operational, and clinical considerations will be key for navigating ongoing transformation in drug delivery devices.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Drug Delivery Devices Market, by Product Type
8.1. Injection Devices
8.1.1. Syringes
8.1.1.1. Conventional Syringes
8.1.1.2. Safety Syringes
8.1.1.3. Prefilled Syringes
8.1.2. Pen Injectors
8.1.2.1. Disposable Pen Injectors
8.1.2.2. Reusable Pen Injectors
8.1.3. Autoinjectors
8.1.3.1. Disposable Autoinjectors
8.1.3.2. Reusable Autoinjectors
8.1.4. Needle-Free Injectors
8.2. Infusion Devices
8.2.1. External Infusion Pumps
8.2.1.1. Insulin Pumps
8.2.1.2. Ambulatory Infusion Pumps
8.2.1.3. Volumetric Infusion Pumps
8.2.1.4. Syringe Infusion Pumps
8.2.2. Implantable Infusion Pumps
8.3. Inhalation Devices
8.3.1. Metered Dose Inhalers
8.3.2. Dry Powder Inhalers
8.3.3. Nebulizers
8.3.3.1. Jet Nebulizers
8.3.3.2. Ultrasonic Nebulizers
8.3.3.3. Mesh Nebulizers
8.4. Transdermal Delivery Devices
8.4.1. Passive Transdermal Patches
8.4.2. Active Transdermal Systems
8.4.2.1. Microneedle Patches
8.4.2.2. Iontophoresis Devices
8.5. Implantable Devices
8.5.1. Biodegradable Implants
8.5.2. Nonbiodegradable Implants
9. Drug Delivery Devices Market, by Therapeutic Area
9.1. Metabolic Disorders
9.1.1. Diabetes
9.1.2. Obesity
9.2. Oncology
9.2.1. Solid Tumors
9.2.2. Hematologic Malignancies
9.3. Cardiovascular Diseases
9.3.1. Hypertension
9.3.2. Heart Failure
9.4. Respiratory Diseases
9.4.1. Asthma
9.4.2. Chronic Obstructive Pulmonary Disease
9.4.3. Cystic Fibrosis
9.5. Autoimmune And Inflammatory Diseases
9.5.1. Rheumatoid Arthritis
9.5.2. Multiple Sclerosis
9.5.3. Inflammatory Bowel Disease
9.6. Infectious Diseases
9.6.1. Viral Infections
9.6.2. Bacterial Infections
9.7. Neurological Disorders
9.7.1. Epilepsy
9.7.2. Parkinson Disease
9.7.3. Alzheimer Disease
9.8. Pain Management
9.8.1. Acute Pain
9.8.2. Chronic Pain
9.9. Hormonal Disorders
9.9.1. Growth Hormone Deficiency
9.9.2. Reproductive Hormone Disorders
10. Drug Delivery Devices Market, by End User
10.1. Hospitals
10.1.1. Tertiary Care Hospitals
10.1.2. Secondary Care Hospitals
10.2. Clinics
10.2.1. Specialty Clinics
10.2.2. Primary Care Clinics
10.3. Ambulatory Surgical Centers
10.4. Home Care Settings
10.4.1. Self Administration
10.4.2. Home Health Nurse Administration
10.5. Diagnostic Centers
10.6. Long Term Care Facilities
10.6.1. Nursing Homes
10.6.2. Rehabilitation Centers
11. Drug Delivery Devices Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Retail Pharmacies
11.2.1. Chain Pharmacies
11.2.2. Independent Pharmacies
11.3. Online Pharmacies
12. Drug Delivery Devices Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Drug Delivery Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Drug Delivery Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Drug Delivery Devices Market
16. China Drug Delivery Devices Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. 3M Company
17.6. AptarGroup, Inc.
17.7. Baxter International Inc.
17.8. Becton, Dickinson and Company
17.9. Bespak Europe Ltd.
17.10. Gerresheimer AG
17.11. GlaxoSmithKline plc
17.12. Haselmeier GmbH
17.13. Insulet Corporation
17.14. Johnson & Johnson
17.15. Medtronic plc
17.16. Merck & Co., Inc.
17.17. Nemera France S.A.S.
17.18. Novartis AG
17.19. Owen Mumford Ltd.
17.20. Pfizer Inc.
17.21. Portal Instruments, Inc.
17.22. Roche Diabetes Care, Inc.
17.23. Sanofi S.A.
17.24. SHL Medical AG
17.25. Tandem Diabetes Care, Inc.
17.26. West Pharmaceutical Services, Inc.
17.27. West Pharmaceutical Services, Inc.
17.28. Ypsomed Holding AG
List of Figures
FIGURE 1. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CONVENTIONAL SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CONVENTIONAL SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CONVENTIONAL SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISPOSABLE PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISPOSABLE PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISPOSABLE PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL DELIVERY DEVICES, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PASSIVE TRANSDERMAL PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PASSIVE TRANSDERMAL PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PASSIVE TRANSDERMAL PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ACTIVE TRANSDERMAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ACTIVE TRANSDERMAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ACTIVE TRANSDERMAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ACTIVE TRANSDERMAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MICRONEEDLE PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MICRONEEDLE PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MICRONEEDLE PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IONTOPHORESIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IONTOPHORESIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IONTOPHORESIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY BIODEGRADABLE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY BIODEGRADABLE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY BIODEGRADABLE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NONBIODEGRADABLE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NONBIODEGRADABLE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NONBIODEGRADABLE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY OBESITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY OBESITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY OBESITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HYPERTENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HYPERTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOIMMUNE AND INFLAMMATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOIMMUNE AND INFLAMMATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOIMMUNE AND INFLAMMATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOIMMUNE AND INFLAMMATORY DISEASES, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PARKINSON DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PARKINSON DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ALZHEIMER DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ALZHEIMER DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ACUTE PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ACUTE PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HORMONAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HORMONAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HORMONAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REPRODUCTIVE HORMONE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REPRODUCTIVE HORMONE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REPRODUCTIVE HORMONE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTH NURSE ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTH NURSE ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTH NURSE ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY LONG TERM CARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NURSING HOMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 259. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 260. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 262. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 265. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 268. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 271. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 281. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 282. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 283. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 284. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
TABLE 285. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 286. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, 2018-2032 (USD MILLION)
TABLE 287. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 288. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 289. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 290. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 291. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL DELIVERY DEVICES, 2018-2032 (USD MILLION)
TABLE 292. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY ACTIVE TRANSDERMAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 293. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 294. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 295. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 296. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 297. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 298. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2032 (USD MILLION)
TABLE 299. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOIMMUNE AND INFLAMMATORY DISEASES, 2018-2032 (USD MILLION)
TABLE 300. AMERICAS DRUG DE

Companies Mentioned

The key companies profiled in this Drug Delivery Devices market report include:
  • 3M Company
  • AptarGroup, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Haselmeier GmbH
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Merck & Co., Inc.
  • Nemera France S.A.S.
  • Novartis AG
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • Portal Instruments, Inc.
  • Roche Diabetes Care, Inc.
  • Sanofi S.A.
  • SHL Medical AG
  • Tandem Diabetes Care, Inc.
  • West Pharmaceutical Services, Inc.
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 310.07 Billion
Forecasted Market Value ( USD ) by 2032 $ 599.37 Billion
Compound Annual Growth Rate11.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Needle-Free Drug Delivery Devices Market Report 2025 - Product Image

Needle-Free Drug Delivery Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Connected Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Connected Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
COVID-19 Drug Delivery Devices - Global Strategic Business Report - Product Image

COVID-19 Drug Delivery Devices - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Drug Delivery Devices Market Report 2025 - Product Image

Drug Delivery Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.